Takura AB
ABActiveOrg 5590766738Nanna Svartz Väg 4, 171 65 SolnaBusiness and other management consultancy activities· NACE 7020Est. 2016 · 10 years old2 employees
Loading company…
Overview
Takura AB is a Swedish AB based in Solna, operating in the Business and other management consultancy activities sector. Incorporated in 2016, the company has 2 employees and reported revenue of SEK 4.4m in its latest annual filing.
Revenue 2025
4.4M SEK
−1% vs 2024
EBITDA margin
−78.4 %
+19% vs 2024
Net profit 2025
-3.4M SEK
+8% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
98.5 %
Very strongAmong the 20% highest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
8.6×
StrongAmong the 30% highest rated companies in the industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
-2.2 %
WeakAmong the 30% lowest rated companies in the industry
20212025
EBITDA — year on year
SEK millionsKey figures
Annual report 2025| Revenue | 4.4M SEK | -1% |
| EBITDA | -3.4M SEK | +19% |
| Net profit | -3.4M SEK | +8% |
| Total assets | 155.9M SEK | +8% |
| Equity | 153.5M SEK | +10% |
| Employees | 2 | — |
Company information
Legal name
Takura AB
Org number
5590766738
Legal form
Aktiebolag
NACE code
Founded
16 September 2016 · 10 years
Share capital
SEK 1,032,304
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med Båtelson, Per Jonas Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska, direkt eller indirekt genom hel- eller delägda bolag, bedriva forskning, utveckling, behandling, produktion och försäljning av innovativa metoder för att behandla olika sjukdomstillstånd. Bolaget ska även tillhandahålla konsulttjänster med avseende på det föregående samt bedriva därmed förenlig verksamhet. Bolaget får dessutom handla med noterade och onoterade värdepapper.
(no translation available)
Contact
Address
Nanna Svartz Väg 4, 171 65 Solna
Email
ht.hallberg@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Takura AB reported revenue of SEK 4.4m, a decrease of 1% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 3.4m, and the EBITDA margin stood at -78.4%.
At the end of 2025, equity financed 98.5% of the balance sheet, and current assets covered short-term debt 8.6 times.
Financials
Revenue
SEK thousandsEBITDA
SEK millionsIncome statement
SEK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4,355 | 4,380 | 2,973 | 1,736 | 1,785 |
| Staff expenses | -5,360 | -5,152 | — | — | — |
| EBITDA | -3,413 | -4,229 | -8,136 | -8,435 | -11,582 |
| Depreciation & amort. | — | — | -0 | -0 | -0 |
| EBIT | -3,413 | -4,229 | -8,136 | -8,435 | -11,582 |
| Net financials | 23 | 547 | -12,637 | 349 | -171 |
| Profit before tax | -3,390 | -3,682 | -14,631 | -8,086 | -11,754 |
| Tax | — | -8 | -0 | -0 | -0 |
| Net profit | -3,390 | -3,689 | -14,631 | -8,086 | -11,754 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
SEK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 155,886 | 144,368 | 106,095 | 133,956 | 96,364 |
| Equity | 153,502 | 140,014 | 102,238 | 130,506 | 91,633 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 2,384 | 4,354 | 3,857 | 3,450 | 4,731 |
| Total debt | 2,384 | 4,354 | 3,857 | 3,450 | 4,731 |
Financial ratios
5-year trendEBITDA margin
-78.4 %
20212025
Equity ratio
98.5 %
Very strongAmong the 20% highest rated companies in the industry
20212025
Return on equity
-2.2 %
WeakAmong the 30% lowest rated companies in the industry
20212025
Net profit margin
-77.8 %
Very weakAmong the 10% lowest rated companies in the industry
20212025
Asset turnover
0.03×
WeakAmong the 30% lowest rated companies in the industry
20212025
Debt / equity
0.02×
Very strongAmong the 10% highest rated companies in the industry
20212025
Sector performance
25 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginVery strong
Among the 20% highest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginVery weak
Among the 20% lowest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginVery weak
Among the 10% lowest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Weak
Among the 30% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Weak
Among the 30% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Weak
Among the 30% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Weak
Among the 30% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioVery weak
Among the 20% lowest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioStrong
Among the 30% highest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Cash ratioVery strong
Among the 20% highest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityVery strong
Among the 10% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Cash conversion ratioAverage
Around the average of companies in the same industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Quick ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Fixed assets to long-term capitalNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Debt & solvency
Solidity ratioVery strong
Among the 20% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery strong
Among the 10% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityVery strong
Among the 10% highest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityVery strong
Among the 20% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtVery weak
Among the 10% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery weak
Among the 20% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageVery weak
Among the 10% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtStrong
Among the 30% highest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginWeak
Among the 30% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverWeak
Among the 30% lowest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Equity to contributed capitalVery strong
Among the 10% highest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityStrong
Among the 40% highest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtVery strong
Among the 20% highest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Annual reports & filings
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SJ Chief Auditor | Chief Auditor | 2021 |
PJ Chief Executive Officer | Chief Executive Officer | 2020 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
HF Chairman | Chairman | 2020 |
FF Board of Directors | Board of Directors | 2026 |
PG Board of Directors | Board of Directors | 2022 |
HP Board of Directors | Board of Directors | 2026 |
LC Board of Directors | Board of Directors | 2022 |
SL Board of Directors | Board of Directors | 2020 |
Former (5)
SL Deputy Board Member | Deputy Board Member | 2023 – 2023 |
HG Board of Directors | Board of Directors | 2020 – 2025 |
EM Board of Directors | Board of Directors | 2023 – 2023 |
LJ Board of Directors | Board of Directors | 2020 – 2025 |
SO Deputy Board Member | Deputy Board Member | 2023 – 2023 |
Shareholders
Active legal ownersNo shareholder data available.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
Takura AB (this company)
Takura Holding Ltd.100% ownedHorkos 5181 AB100% ownedSwedish StromaBio AB100% ownedCuraCell TX AB93% ownedPolybiocept Gmbh100% ownedCuracell Germany GmbH100% ownedPolybiocept GmbH100% ownedCuracell Germany Gmbh100% ownedCellcolabs AB70% ownedBoard network connections
Board members of Takura AB also hold positions in 321 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sandra Jenny Carina Lindvall | Chief Auditor | 190 companiesMany roles |
| Stig Ola Winqvist | Deputy Board Member | 19 companiesMany roles |
| Per Gunnar Båtelson | Board of Directors | 17 companiesMany roles |
| Hans Gustaf Lindroth | Board of Directors | 15 companiesMany roles |
| Hans Fredrik Mattsson | Chairman | 15 companiesMany roles |
| Erik Mattias Engellau-Nilsson | Board of Directors | 12 companiesMany roles |
| Hans Peter Agardh | Board of Directors | 12 companiesMany roles |
| Simon Lindfors | Board of Directors | 11 companiesMany roles |
| Per Jonas Båtelson | Chief Executive Officer | 10 companiesMany roles |
| Fredrik Franz Johan Wilhelm Buch | Board of Directors | 9 companiesMany roles |
| Leif Jörgen Ingemar Lundblad | Board of Directors | 7 companiesMany roles |
| Lena Charlotte Holtback | Board of Directors | 3 companies |
| Stefan Lars Eddie Svensson | Deputy Board Member | 1 company |
Frequently asked questions
What is the Org number of Takura AB?
Takura AB is registered with Bolagsverket / SCB under Org 5590766738.
What is the revenue of Takura AB?
Takura AB reported revenue of SEK 4.4m in 2025.
How many employees does Takura AB have?
Takura AB employs 2 people as of the latest annual report.
Who is the CEO of Takura AB?
Per Jonas Båtelson is the CEO of Takura AB, in role since 2020.
Who is the chairman of Takura AB?
Hans Fredrik Mattsson chairs the board of Takura AB, in role since 2020.
Where is Takura AB headquartered?
Takura AB's registered address is Nanna Svartz Väg 4.